Pacific Biosciences of California Inc (NASDAQ:PACB) shares, rose in value on Wednesday, June 18, with the stock price up by 0.77% to the previous day’s close as strong demand from buyers drove the stock to $1.31.
Actively observing the price movement in the last trading, the stock closed the session at $1.30, falling within a range of $1.25 and $1.34. The value of beta (5-year monthly) was 2.101. Referring to stock’s 52-week performance, its high was $2.72, and the low was $0.85. On the whole, PACB has fluctuated by 28.43% over the past month.
With the market capitalization of Pacific Biosciences of California Inc currently standing at about $393.11 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-08.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that PACB’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium-term indicators have put the stock in the category of 50% Sell while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the price of PACB currently trading nearly 19.33% and 15.42% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 62.10, while the 7-day volatility ratio is showing 8.31% which for the 30-day chart, stands at 7.10%. Furthermore, Pacific Biosciences of California Inc (PACB)’s beta value is 2.10, and its average true range (ATR) is 0.10.
A comparison of Pacific Biosciences of California Inc (PACB) with its peers suggests the former has fared considerably weaker in the market. PACB showed an intraday change of 0.77% in last session, and over the past year, it shrunk by -25.57%%.
Data on historical trading for Pacific Biosciences of California Inc (NASDAQ:PACB) indicates that the trading volumes over the past 10 days have averaged 9.97 and over the past 3 months, they’ve averaged 8.71 million. According to company’s latest data on outstanding shares, there are 300.04 million shares outstanding.
Nearly 11.97% of Pacific Biosciences of California Inc’s shares belong to company insiders and institutional investors own 65.75% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 52.02 million shares as on 2025-05-30, resulting in a short ratio of 5.55. According to the data, the short interest in Pacific Biosciences of California Inc (PACB) stood at 1973.00 of shares outstanding as of 2025-05-30; the number of short shares registered in 2025-04-30 reached 49.21 million. The stock has fallen by -28.42% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the PACB stock heading into the next quarter.
